Efficacy and safety of lamivudine treatment in late pregnancy with high HBV DNA: A perspective for mother and infants

Journal of Infection in Developing Countries

Volumn 5, Issue 4, 2011, Pages 303-306

  Köse, Sükran ^a   Türken, Melda ^a   Devrim, Ilker ^b   Taner, Cüneyt ^c  

^a Department of Infectious Diseases and Clinic Microbiology ^*  (Turkey)

^b MINISTRY OF HEALTH   (Turkey)

^c Izmir Aegean Obstetrics and Gynecology Teaching Hospital   (Turkey)

Author keywords

Chronic hepatitis B infection; Lamivudine; Pregnancy

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; LAMIVUDINE;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; BIOCHEMISTRY; CHRONIC HEPATITIS; CLINICAL ARTICLE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; PREGNANT WOMAN; RETROSPECTIVE STUDY; SEROLOGY; THIRD TRIMESTER PREGNANCY; VIRUS LOAD; VIRUS REPLICATION;

HEPATITIS B VIRUS;

EID: 79955855125     PISSN: 20366590     EISSN: 19722680     Source Type: Journal    
DOI: 10.3855/jidc.1398     Document Type: Article

References (19)

1. Van Nunen AB, de Man RA, Heijtink RA, Niesters HG, Schalm SW (2000) Lamivudine in the last 4 weeks of pregnancy to prevent perinatal transmission in highly viremic chronic hepatitis B patients. J Hepatol 32: 1040-1041.
2. Seef LB and Koff RS (1984) Passive and active immunoprophylaxis of hepatitis B. Gastroenterology 86: 958-981.
3. World Health Organization (1998) Hepatitis B and breastfeeding. J Int Assoc Physicians AIDS Care 4: 20-21.
4. Okada K, Kamiyama I, Inomata M, Imai M, Miyakawa Y, Mayumi M (1976) E antigen and anti e in the serum of asymptomatic carrier mothers as indicators of positive and negative transmission of hepatitis B virus to their infants. N Engl J Med 294: 746-749.
5. Stevens CE, Beasley RP, Tsui J, Lee WC (1975) Vertical transmission of hepatitis B antigen in Taiwan. N Engl J Med 292: 771-774.
6. Stevens CE, Toy PT, Tong MJ, Taylor PE, Vyas GN, Nair PV, Gudavalli M, Krugman S (1985) Perinatal hepatitis B virus transmission in the United States: prevention by passive-active immunization. JAMA 253: 1740-1745.
7. Del Canho R, Grosheide PM, Mazel JA, Heijtink RA, Hop WCJ, Gerards LJ, de Gast GC, Fetter WPF, Zwijneberg J, Schalm SW (1997) Ten-year neonatal hepatitis B vaccination program, The Netherlands, 1982-1992: Protective efficacy and long-term immunogenicity. Vaccine 15: 1624-1630.
8. Ip HM, Wong VCW, Lelie PN, Kuhns MC, Reesink HW (1989) Prevention of hepatitis B virus carrier state in infants according to maternal serum levels of HBV DNA. Lancet 1: 406-410.
9. Faucher P, Batallan A, Bastian H, Matheron S, Morau G, Madelenat P, Benifla JL (2001) Management of pregnant women with HIV at Bichat Hospital between 1990 and 1998: analysis of 202 pregnancies. Gynecol Obstet Fertil 29: 211-225.
10. Moodley J, Moodley D, Pillay K, Coovadia H, Saba J, van Leeuwen R, Goodwin C, Harrigan PR, Moore KH, Stone C, Plumb R, Johnson MA (1998) Pharmacokinetics and antiretroviral activity of lamivudine alone or when coadministered with zidovudine in human immunodeficiency virus type 1-infected pregnant women and their offspring. J Infect Dis 178: 1327-1333.
11. Johnson MA, Moore KHP, Yuen GJ, Bye A, Pakes GE (1999) Clinical pharmacokinetics of lamivudine. Clin Pharmacokinet 36: 41-66.
12. Xu WM, Cui YT, Wang L, Yang H, Liang ZQ, Li XM, Zhang SL, Qiao FY, Campbell F, Chang CN, Gardner S, Atkins M (2009) Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study. J Viral Hepat 16: 94-103.
13. Akman SA, Kose S, Halicioglu O. (2010). Lamivudine and adefovir resistance in children and young adults with chronic hepatitis B. Int J Infect Dis 14: e236-9.
14. Van Zonneveld M, van Nunen AB, Niesters HG, de Man RA, Schalm SW, Janssen HL (2003) Lamivudine treatment during pregnancy to prevent perinatal transmission of hepatitis B virus infection. J Viral Hepat 10: 294-297
15. Yang H, Chen R, Li Z, Zhou G, Zhao Y, Cui D, Li S, Han C, Yang L (2002) Analysis of fetal distress in pregnancy with hepatitis B virus infection. Zhonghua Fu Chan Ke Za Zhi 37: 211-213.
16. Xu XW and Chen YG (2006) Current therapy with nucleoside/nucleotide analogs for patients with chronic hepatitis B. Hepatobiliary Pancreat Dis Int 5: 350-359.
17. Su GG, Pan KH, Zhao NF, Fang SH, Yang DH, Zhou Y (2004) Efficacy and safety of lamivudine treatment for chronic hepatitis B in pregnancy. World J Gastroenterol 10: 910-912.
18. Deverbhavi H, Kremers WK, Dierkhising R, Padmanabhan L (2008) Pregnancy-associated acute liver disease and acute viral hepatitis: Differentiation, course and outcome. J Hepatol 49: 930-935.
19. Hung JH, Chu CJ, Sung PL, Chen CY, Chao KC, Yang MJ, Hung SC (2008) Lamivudine therapy in the treatment of chronic hepatitis B with acute exacerbation during pregnancy. J Chin Med Assoc 71: 155-158.